Thymulin

Biology of the cell · 2015

Researchers reviewed the effectiveness of a synthetic drug called FTS (Salirasib) that targets the Ras oncogene, which is involved in many cancers. They found that combining FTS with other drugs can significantly enhance treatment outcomes, suggesting its potential use in cancer and inflammation therapies.

• Researchers observed that FTS acts as a strong antagonist to the Ras oncogene, which is linked to over 30% of human cancers.
• The study highlighted that FTS works effectively in combination with various other therapeutic agents.
• This combination approach shows promise for improving treatment outcomes in cancer and inflammatory conditions.

Annals of the New York Academy of Sciences · 2006

Researchers found that thymulin, a peptide known for its role in the immune system, can also affect pain sensitivity and inflammation. The study observed that thymulin and a related peptide may reduce pain and inflammatory responses, suggesting potential use as new analgesic and anti-inflammatory agents.

• Thymulin injections at low doses increased pain sensitivity, while higher doses of thymulin or its analogue reduced inflammatory pain.
• The analogue peptide, PAT, showed stronger analgesic effects compared to other anti-inflammatory drugs at lower concentrations.
• Thymulin demonstrated a neuroprotective role in the brain by reducing inflammation and the activation of proinflammatory factors.

Peptides · 2004

Researchers reviewed the role of thymulin, a hormone produced in the thymus, and its interactions with the neuroendocrine system. They found that thymulin is influenced by this system and may play a significant role in the communication between the thymus and the pituitary gland.

• Thymulin is a hormone that aids in the development of T-cells, which are crucial for the immune system.
• The production of thymulin is significantly affected by the neuroendocrine system.
• Thymulin may also influence the functioning of the pituitary gland, suggesting a complex relationship between these two systems.

Medical oncology and tumor pharmacotherapy · 1989

Researchers studied thymulin, a hormone produced by thymic cells that requires zinc to function. They found that thymulin plays a significant role in the development and activity of T-cells, particularly in enhancing the function of suppressor T-cells. This natural hormone shows promise as a potential immunoregulatory agent in clinical applications.

• Thymulin is a nonapeptide hormone that relies on zinc for its biological activity.
• It induces differentiation and enhances functions of various T-cell subsets.
• The most notable effect observed was on suppressor T-cells, suggesting potential clinical uses.

The American journal of clinical nutrition · 1988

Researchers studied the thymus glands of malnourished Senegalese children to understand how nutritional deficiencies and infections affect immune function. They found that severe malnutrition led to smaller thymus glands with lower levels of thymulin, a key immune factor, while zinc levels were high and mainly linked to infections.

• Researchers observed that severe forms of malnutrition resulted in tiny thymus glands with significantly reduced thymulin levels.
• The zinc content in the thymus was consistently high, regardless of nutritional status, and was primarily associated with the presence of infections.
• The study concluded that thymic atrophy and low thymulin levels are linked to severe protein-energy malnutrition rather than systemic infections or low zinc levels.

The American journal of clinical nutrition · 1985

Researchers studied the levels of thymulin, a hormone related to immune function, in 15 women with anorexia nervosa. They found that thymulin activity was significantly lower in these patients compared to healthy individuals, which may be linked to malnutrition and hormonal changes associated with the disorder.

• Thymulin activity was significantly reduced in anorexia nervosa patients compared to healthy controls.
• Patients had very low levels of triiodothyronine (T3) but normal levels of other hormones like thyroxine (T4) and cortisol.
• The decrease in thymulin may contribute to changes in immune responses and energy levels in patients with advanced weight loss.

Thymus · 1982

Researchers studied the location of a protein called facteur thymique sérique (FTS) in the thymus of normal and autoimmune mice. They found that in normal mice, FTS was present in specific cell structures, while in autoimmune mice, FTS appeared in granules within the cells, indicating a change in how this protein is stored during autoimmune processes.

• Researchers observed that in normal mice, FTS was found in the cytoplasmic vacuoles of thymus cells.
• In aged autoimmune mice, FTS was located in granules within epithelial cells, rather than in the same structures as in normal mice.
• The granules containing FTS showed a unique crystalline structure, suggesting a different storage mechanism during autoimmune conditions.

Clinical and experimental immunology · 1982

Researchers developed a specific monoclonal antibody against a thymic hormone called facteur thymique serique (FTS). They found that this antibody could effectively identify FTS in human serum without reacting to other similar substances. This advancement could aid in better understanding the role of FTS in health.

• Researchers generated a monoclonal antibody (MA-FTS) that specifically targets FTS.
• MA-FTS did not cross-react with other thymic hormones or unrelated peptides.
• The antibody was able to recognize FTS in human serum and absorb its activity.

Clinical and experimental immunology · 1980

Researchers studied a substance called facteur thymique sérique (FTS), which is important for T cell development and is found in the thymus. They confirmed that FTS binds to specific cells in the thymus using specialized antibodies, demonstrating its role in the immune system.

• Researchers found that FTS is a nonapeptide crucial for T cell differentiation.
• The study confirmed that FTS is dependent on the thymus, as it disappears after thymectomy.
• The binding of antibodies to thymic cells was specifically linked to FTS, validated by preincubation with synthetic FTS.

Thymus · 1980

Researchers studied the localization of a protein called facteur thymique sérique (FTS) in thymic epithelial cells using advanced imaging techniques. They found that FTS is stored in various cytoplasmic structures within these cells, suggesting a potential role in cellular processes or responses to certain conditions.

• Researchers observed that FTS antibodies labeled different sizes of cytoplasmic vacuoles in thymic epithelial cells.
• The study found that some cells contained crystalline structures that reacted strongly with FTS antibodies.
• Researchers noted the presence of specific markers indicating that some FTS-positive cells originated from the thymic medulla.